نتایج جستجو برای: tb vaccine

تعداد نتایج: 133682  

2016
Carolina Perdomo Ulrike Zedler Anja A. Kühl Laura Lozza Philippe Saikali Leif E. Sander Alexis Vogelzang Stefan H. E. Kaufmann Andreas Kupz

Mycobacterium bovis Bacille Calmette-Guérin (BCG) is the only licensed vaccine against tuberculosis (TB), yet its moderate efficacy against pulmonary TB calls for improved vaccination strategies. Mucosal BCG vaccination generates superior protection against TB in animal models; however, the mechanisms of protection remain elusive. Tissue-resident memory T (TRM) cells have been implicated in pro...

2017
Pere-Joan Cardona

This is a call to encourage the search for a new vaccine to stop the progression of Mycobacterium tuberculosis infection to tuberculosis (TB) disease. TB is a highly discreet and stigmatized disease, with a massive impact on human health. It has killed 1.2 billion people in the last 200 years and still kills 1.5 million people per year. Over the last 20 years, the TB vaccine field has experienc...

2016
Zheng Zhong Xu Xiang Chen Ting Hu Chuang Meng Xiao Bo Wang Yan Rao Xiao Ming Zhang Yue Lan Yin Zhi Ming Pan Xin An Jiao

Mycobacterium bovis bacillus Calmette-Guérin (BCG) is currently the only vaccine available for preventing tuberculosis (TB), however, BCG has varying success in preventing pulmonary TB. In this study, a recombinant BCG (rBCG::Ag85A) strain overexpressing the immunodominant Ag85A antigen was constructed, and its immunogenicity and protective efficacy were evaluated. Our results indicated that th...

Journal: :iranian journal of veterinary research 2007
t. taghipour bazargani s. charkhkar f. sadeghi m. khalaj m. rashtibaf

this study was carried out to control johne’s disease (jd) without interfering with tuberculosis (tb)control programme. a dairy herd (n>1500 heads) was used over a period of 6 years, from 1994 to 1999 forthis investigation. the herd had a history of heavy infection with mycobacterium avium paratuberculosis(map) with culling rates of 1.5 and 5%, in 1991 and 1995, respectively. the mean annual lo...

2017
Eric Warren Garrett Teskey Vishwanath Venketaraman

Neutrophils have a significant yet controversial role in the innate immune response to Mycobacterium tuberculosis (M. tb) infection, which is not yet fully understood. In addition to neutrophils' well-known effector mechanisms, they may also help control infection of M. tb through the formation of neutrophil extracellular traps (NETs), which are thought to further promote the killing of M. tb b...

2011
Angela M Minassian Rosalind Rowland Natalie E R Beveridge Ian D Poulton Iman Satti Stephanie Harris Hazel Poyntz Matthew Hamill Kristin Griffiths Clare R Sander David R Ambrozak David A Price Brenna J Hill Joseph P Casazza Daniel C Douek Richard A Koup Mario Roederer Alan Winston Jonathan Ross Jackie Sherrard Guy Rooney Nicola Williams Alison M Lawrie Helen A Fletcher Ansar A Pathan Helen McShane

Objectives Control of the tuberculosis (TB) epidemic is a global health priority and one that is likely to be achieved only through vaccination. The critical overlap with the HIV epidemic requires any effective TB vaccine regimen to be safe in individuals who are infected with HIV. The objectives of this clinical trial were to evaluate the safety and immunogenicity of a leading candidate TB vac...

Ali Asghar Baghani, Arman Mosavat, Hadi Farsiani, Hamid Sadeghian Kiarash Ghazvini, Masoud Yousefi Mohammad Reza Akbari Eydgahi, Saeid Amel Jamehdar, Saman Soleimanpour, Seyed Abdolrahim Rezaee Zahra Meshkat

Objective(s): Despite treatment with antibiotics and vaccination with BCG, tuberculosis (TB) is still considered as one of the most important public health problems in the world. Therefore, designing and producing a more effective vaccine against TB seems urgently. In this study, immunogenicity of a fusion protein which consisting or comprising CFP-10 from Mycobacterium tuberculosis and the Fc-...

Background & objective:  Tuberculosis (TB) remains a major cause of death around the world. Bacillus Calmette Guérin (BCG) is the only vaccine used in TB prevention that has a protective effect in children, but its effectiveness declines in adults. Design and development of new vaccines is the most effective way against TB. The aim of this study was to design and construc...

2011
Timothy Lahey Brian K. Mitchell Robert D. Arbeit Siddharth Sheth Mecky Matee C. Robert Horsburgh Todd MacKenzie Lillian Mtei Muhammad Bakari Jenni M. Vuola Kisali Pallangyo C. Fordham von Reyn

BACKGROUND Surrogate immunologic markers for natural and vaccine-mediated protection against tuberculosis (TB) have not been identified. METHODS HIV-infected adults with childhood BCG immunization entering the placebo arm of the DarDar TB vaccine trial in Dar es Salaam, Tanzania, were assessed for interferon gamma (IFN-γ) responses to three mycobacterial antigen preparations--secreted Mycobac...

Objective(s): Infection with tuberculosis (TB) is regarded as a major health issue. Due to the emergence of antibiotic resistance during TB treatment, prevention via vaccination is one of the most effective ways of controlling the infection. DNA vaccines are developed at a greater pace due to their ability in generating a long-lasting immune response, higher safety com...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید